Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare neurologic disease characterized by the presence of Duane retraction syndrome (i. e. a congenital cranial dysinnervation disorder with unilateral or bilateral limitation of abduction and/or adduction of the eye, as well as globe retraction and palpebral fissure narrowing on attempted adduction) in combination with congenital unilateral or bilateral hearing loss. The sidedness of hearing loss corresponds to the sidedness of the retraction syndrome.
Biomarker and diagnostic research for Duane retraction syndrome with congenital deafness has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Duane retraction syndrome with congenital deafness.
27 publications have been identified in PubMed for Duane retraction syndrome with congenital deafness. Research spans Epidemiology / Natural History (37%), Clinical Trial Publication (15%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 10 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Duane retraction syndrome with congenital deafness
Clinical study results |
4 |
15% |
Laboratory research | 4 | 15% |
Testing and diagnosis research | 3 | 11% |
Patient case studies | 3 | 11% |
Other research | 1 | 4% |
Research summaries | 1 | 4% |
New treatment approaches | 1 | 4% |
Olchanyi MD (2026). [PMID: 41650217](https://pubmed.ncbi.nlm.nih.gov/41650217/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Runge CL (2026). [PMID: 40829719](https://pubmed.ncbi.nlm.nih.gov/40829719/). *Int J Radiat Oncol Biol Phys*. [Clinical Trial Publication]
Borre ED (2026). [PMID: 41632497](https://pubmed.ncbi.nlm.nih.gov/41632497/). *J Gerontol A Biol Sci Med Sci*. [Epidemiology / Natural History]
Eliyahu A (2026). [PMID: 41898877](https://pubmed.ncbi.nlm.nih.gov/41898877/). *Genes (Basel)*. [Diagnostic / Biomarker]
Fischer RL (2026). [PMID: 40864298](https://pubmed.ncbi.nlm.nih.gov/40864298/). *Z Gerontol Geriatr*. [Epidemiology / Natural History]
Williams E (2025). [PMID: 41394796](https://pubmed.ncbi.nlm.nih.gov/41394796/). *Wellcome Open Res*. [Gene Therapy / Novel Therapeutics]
Curhan SG (2025). [PMID: 41404663](https://pubmed.ncbi.nlm.nih.gov/41404663/). *Am J Epidemiol*. [Epidemiology / Natural History]
Bass JK (2025). [PMID: 40310640](https://pubmed.ncbi.nlm.nih.gov/40310640/). *JAMA Oncol*. [Epidemiology / Natural History]
Du Q (2025). [PMID: 39936598](https://pubmed.ncbi.nlm.nih.gov/39936598/). *J Int Adv Otol*. [Clinical Trial Publication]
Dillard LK (2025). [PMID: 40310632](https://pubmed.ncbi.nlm.nih.gov/40310632/). *JAMA Otolaryngol Head Neck Surg*. [Epidemiology / Natural History]